Atlas Trials

Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery

Clinical trial NCT02607423 · WITHDRAWN

Trial details

NCT number
NCT02607423
Sponsor
ECOG-ACRIN Cancer Research Group
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Stage IIIA Non-Small Cell Lung Cancer
Start date
2015-11-19
Primary completion
2017-01-31
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.